- CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry — Recruiting • NCT04688190.
- Registry tracking real-world outcomes in patients receiving catheter-based mitral valve replacement across multiple countries.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
This multinational, investigator-initiated registry aims to investigate clinical outcomes of patients undergoing transcatheter mitral valve replacement (TMVR). The registry primarily focuses on patients treated with TMVR in real-world clinical practice. Patients evaluated for TMVR but not undergoing the procedure are no longer systematically included. Historical data may include such patients who subsequently underwent alternative treatments, including transcatheter edge-to-edge repair, mitral valve surgery, or medical/conservative therapy. Conditions: Mitral Regurgitation, Mitral Valve Disease, Mitral Annular Calcification Lead Sponsor: Universitätsklinikum Hamburg-Eppendorf Planned Enrollment: 1000 participants